Envase

 

Envase

PHARMACEUTICAL COMPOSITION COMPRISING, AS THICKENING AGENT, A COMPOSITION HAVING POLAR MEDIA THICKENING PROPERTIES
21/03/2024 - A pharmaceutical composition (F) comprising at least one pharmaceutical active principle and as thickener a composition (CA) in the form of an emulsion of the self-invertible water-in-oil type...
METHOD FOR PREDICTING THERAPEUTIC EFFECT OF PHARMACOTHERAPY IN TREATMENT OF SUBJECT WITH METASTATIC PROSTATE CANCER, KIT, ARRAY, AND BIOMARKER
21/03/2024 - A method according to the present invention is a method for predicting the therapeutic effect of pharmacotherapy in the treatment of a subject with metastatic prostate cancer, wherein the...
METHODS OF MANAGING TRAUMATIC BRAIN INJURY
21/03/2024 - This disclosure relates to methods of treating or preventing traumatic brain injury (TBI) or related conditions comprising administering an effective amount of poly [4-styrenesulfonic...
PHARMACEUTICAL FORMS OF A CD73 INHIBITOR
21/03/2024 - The present disclosure relates to pharmaceutical forms of a CD73 inhibitor, polymorphic forms of the pharmaceutical forms, pharmaceutical compositions comprising the pharmaceutical forms, and...
COMPOSICIONES ACTIVADORAS DE STING POLIVALENTE Y USOS DE LAS MISMAS.
04/05/2023 - Described herein are therapeutic pH responsive compositions useful for the treatment of cancer. The compositions involve combining a STING activating polymer micelle, such as PC7A, with a...
COPOLIMEROS DE DIBLOQUE AUTO-MONTADOS COMPUESTOS DE PEGMEMA Y SEGMENTOS POLIMERICOS QUE TIENEN FARMACO.
18/05/2023 - This invention relates to polymer drug conjugates according to formula I, and their use for treatment of diseases such as cancer.
METHOD FOR TREATING NONTUBERCULOUS MYCOBACTERIAL INFECTION
14/03/2024 - The present invention relates to an inhalable pharmaceutical composition comprising clofazimine, or a pharmaceutically acceptable derivative of clofazimine, a clofazimine salt, or a polymorph of...
ULTRALOW MOLECULAR WEIGHT HEPARIN
14/03/2024 - Provided herein are heparin oligomers (e.g., heparin oligomers of Formula (I)), pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers,...
MOLECULAR GLUE COMPOUND BASED ON CEREBLON PROTEIN DESIGN AND USE THEREOF
14/03/2024 - The present disclosure relates to a compound of formula (I) or a salt, an enantiomer, a diastereomer, an isotope-enriched analogue, a solvate, a prodrug or a polymorph thereof, and the use...
UPADACITINIB FORMULATION
14/03/2024 - The present invention is related to pharmaceutical composition of upadacitinib comprising upadacitinib or its pharmaceutically acceptable salt thereof, release controlling polymer, pH modifier and...
BUCCOMUCOADHESIVE PATCH-BASED DRUG DELIVERY SYSTEM FOR TACROLIMUS
14/03/2024 - The present disclosure relates to buccal mucoadhesive patch formulation of tacrolimus loaded in the solid lipid nanoparticles and using the polymeric carrier matrix and pharmaceutically acceptable...
PROCEDIMIENTO Y COMPUESTO PARA SU USO EN EL TRATAMIENTO Y/O PREVENCIÓN DE LA NETOSIS.
16/05/2023 - Described herein is a method for treating and/or preventing a disease or disorder or condition associated with NETosis, the method comprising: administering to a subject a compound as disclosed...
POLIMORFOS DE UN AGONISTA DEL RECEPTOR A DEL ACIDO GAMMA-AMINOBUTIRICO (GABAA) ALFA 5 Y METODOS DE USO EN EL TRATAMIENTO DEL DETERIORO COGNITIVO.
10/05/2023 - Crystalline forms of a GABAA α5 agonist, pharmaceutical compositions and combinations comprising those crystalline forms, their use in methods of treating cognitive impairment associated with...
COMPOSICIONES DE FORMA DE DOSIFICACIÓN QUE COMPRENDEN UN INHIBIDOR DE BTK Y MUTANTES DE ESTE.
09/05/2023 - Provided herewith are pharmaceutical tablet compositions comprising an organic acid (such as fumaric acid) and a compound of Formula (I), or an N-oxide thereof, solvate, polymorph, tautomer,...
PECVD COATED PHARMACEUTICAL PACKAGING
07/03/2024 - An article or vessel is described including a vessel surface and a coating set comprising at least one tie coating, at least one barrier coating, and at least one pH protective coating. For...
ANTICOAGULANT HEPARIN-DERIVED OLIGOSACCHARIDE BIPHENYL DIMER, AND PREPARATION METHOD THEREFOR AND USE THEREOF
07/03/2024 - The present invention relates to an anticoagulant heparin-derived oligosaccharide biphenyl dimer, and a preparation method therefor and a use thereof. The anticoagulant heparin-derived...
BENZO FIVE-MEMBERED NITROGEN RING COMPOUNDS, PREPARATION METHOD THEREFOR, AND MEDICAL USES THEREOF
07/03/2024 - Provided are benzo five-membered nitrogen ring compounds, a preparation method therefor, and the medical uses thereof. Specifically provided are: benzo five-membered nitrogen ring compounds, or...
P38?-MK2 INHIBITOR COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USE THEREOF
07/03/2024 - Compounds represented by formula I, and racemates, stereoisomers, tautomers, isotope-labeled substances, nitrogen oxides, solvates, polymorphs, pharmaceutically acceptable salts or prodrugs...
Processo para preparação de um polímero de amina reticulada
27/02/2024 - composições farmacêuticas e métodos de tratamento de um animal, incluindo o ser humano, e métodos de preparo dessas composições. as composições farmacêuticas contêm polímeros de amina...